CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-12 | Furlow Brenda S. SVP - General Counsel | Option exercise · Stock Options (Right to Buy) | −8,000 | 1,600 | ||
| 2019-12-10 | Kummeth Charles R. Chief Executive Officer | Option exercise | +703 | $67.46 | $47K | 136,459 |
| 2019-12-10 | Kummeth Charles R. Chief Executive Officer | Sale | −703 | $222.01 | $156K | 135,756 |
| 2019-12-10 | Kummeth Charles R. Chief Executive Officer | Option exercise · Stock Options (Right to Buy) | −703 | 45,115 | ||
| 2019-12-04 | WIENS HAROLD J Director | Option exercise | +2,000 | $87.83 | $176K | 7,221 |
| 2019-12-04 | WIENS HAROLD J Director | Sale | −485 | $216.47 | $105K | 6,736 |
| 2019-12-04 | WIENS HAROLD J Director | Sale | −514 | $217.29 | $112K | 6,222 |
| 2019-12-04 | WIENS HAROLD J Director | Sale | −921 | $218.75 | $201K | 5,301 |
| 2019-12-04 | WIENS HAROLD J Director | Sale | −80 | $219.31 | $18K | 5,221 |
| 2019-12-04 | WIENS HAROLD J Director | Option exercise · Stock Option (right to buy) | −2,000 | 0 | ||
| 2019-11-29 | Kummeth Charles R. Chief Executive Officer | Sale | −100 | $222.62 | $22K | 135,756 |
| 2019-11-27 | Kummeth Charles R. Chief Executive Officer | Option exercise | +11,772 | $67.46 | $794K | 147,628 |
| 2019-11-27 | Kummeth Charles R. Chief Executive Officer | Sale | −11,772 | $222.12 | $2.6M | 135,856 |
| 2019-11-27 | Kummeth Charles R. Chief Executive Officer | Option exercise · Stock Options (Right to Buy) | −11,772 | 45,818 | ||
| 2019-11-25 | Nusse Roeland Director | Option exercise | +10,000 | $60.46 | $605K | 15,721 |
| 2019-11-25 | Nusse Roeland Director | Option exercise | +5,000 | $61.46 | $307K | 20,721 |
| 2019-11-25 | Nusse Roeland Director | Sale | −8,347 | $219.33 | $1.8M | 12,374 |
| 2019-11-25 | Nusse Roeland Director | Option exercise · Stock Option (right to buy) | −10,000 | 0 | ||
| 2019-11-25 | Nusse Roeland Director | Option exercise · Stock Option (right to buy) | −5,000 | 0 | ||
| 2019-11-22 | Hippel James Chief Financial Officer | Option exercise | +23,651 | $94.35 | $2.2M | 32,958 |
Page 48 of 53 · 1,043 trades